Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

SAPHENAMEDICAL ANTI-EMBOLISM STOCKINGS

K-Number: K101224 · 2010-12-03

Decision Date2010-12-03
Product CodeDWL
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

SAPHENAMEDICAL ANTI-EMBOLISM STOCKINGS is the device name listed in this FDA 510(k) record. The listed applicant is Griffiths and Nielsen, Ltd.. It received FDA 510(k) clearance on 2010-12-03 under 510(k) number K101224. The device is classified under product code DWL. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the SAPHENAMEDICAL ANTI-EMBOLISM STOCKINGS?

SAPHENAMEDICAL ANTI-EMBOLISM STOCKINGS is a medical device that received FDA 510(k) clearance on 2010-12-03. The listed applicant is Griffiths and Nielsen, Ltd.. The 510(k) number is K101224.

When did SAPHENAMEDICAL ANTI-EMBOLISM STOCKINGS receive FDA 510(k) clearance?

SAPHENAMEDICAL ANTI-EMBOLISM STOCKINGS received FDA 510(k) clearance on 2010-12-03, under 510(k) number K101224.

Who is the listed applicant for SAPHENAMEDICAL ANTI-EMBOLISM STOCKINGS?

The FDA 510(k) record lists Griffiths and Nielsen, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for SAPHENAMEDICAL ANTI-EMBOLISM STOCKINGS?

The FDA product code for SAPHENAMEDICAL ANTI-EMBOLISM STOCKINGS is DWL.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: DWL)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑